We have Eyes on Pharma Conferences this week. Don't forget to check PharmaTell Studio for the latests Planners, Insights, and Key Takes.

The MedTech sector seemed to take the brunt of the 2022 market decline but looking to forward there may be light at the end of the tunnel.

We’ve had Eyes On – Some of the Post Holiday /Pre-Earnings News Snippets As the companies and the markets gear up for Results, tucked in...

I've got Eyes On the Review / Preview Articles for the Healthcare Industry. It's interesting to see a snapshot of 2022 and some predictions

After all the quarterly results reporting, we've had eyes on product approvals, resubmissions, and a withdrawal.

We've had Eyes On the Hema space - trying to keep up with the latest data and approvals for Hemophilia, Sickle Cell, and Beta Thalassemia ..